{"disease":{"id":"healthcare-associated-pneumonia","name":"healthcare associated pneumonia"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04915898","title":"Hospital-acquired Pneumonia Prevention: Intervention, Evaluation & Research","phase":"NA","overall_status":"COMPLETED","enrollment_count":8709,"lead_sponsor_name":"Orlando Health, Inc.","has_results":false},{"nct_id":"NCT05979545","title":"EaRly impAct theraPy With Ceftazidime-avibactam Via rapID Diagnostics","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":1900,"lead_sponsor_name":"National University of Singapore","has_results":false},{"nct_id":"NCT05589727","title":"Application of Ventilator-Associated Events (VAE) in Ventilator-Associated Pneumonia (VAP) Notified in Brazil","phase":"","overall_status":"COMPLETED","enrollment_count":987,"lead_sponsor_name":"Giovanna Marssola Nascimento","has_results":false},{"nct_id":"NCT02070757","title":"Safety and Efficacy Study of Ceftolozane/Tazobactam to Treat Ventilated Nosocomial Pneumonia (MK-7625A-008)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":726,"lead_sponsor_name":"Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)","has_results":true},{"nct_id":"NCT03032380","title":"Clinical Study of Cefiderocol (S-649266) for the Treatment of Nosocomial Pneumonia Caused by Gram-negative Pathogens","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":300,"lead_sponsor_name":"Shionogi","has_results":true},{"nct_id":"NCT04438187","title":"Trial of Antimicrobial Restraint in Presumed Pneumonia","phase":"NA","overall_status":"COMPLETED","enrollment_count":186,"lead_sponsor_name":"University of Kansas Medical Center","has_results":false},{"nct_id":"NCT02714595","title":"Study of Cefiderocol (S-649266) or Best Available Therapy for the Treatment of Severe Infections Caused by Carbapenem-resistant Gram-negative Pathogens","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":152,"lead_sponsor_name":"Shionogi","has_results":true}],"total":7},"guidelines":[],"source":"Drug Landscape verified database"}